Quantitative analysis of skeletal muscle mass in patients with rheumatic diseases under glucocorticoid therapy – Comparison among bioelectrical impedance analysis, computed tomography, and magnetic resonance imaging

References

• Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294–314.
   PubMedGoogle Scholar
• Hoffman EP, Nader GA. Balancing muscle hypertrophy and atrophy. Nat Med. 2004;10(6):584–5.
   PubMedGoogle Scholar
• Menconi M, Fareed M, O’Neal P, Poylin V, Wei W, Hasselgren PO. Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med. 2007;35(9 Suppl):S602–8.
   Google Scholar
• Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013;45(10):2163–72.
   PubMedGoogle Scholar
• Pecori Giraldi F, Moro M, Cavagnini F, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of E. Gender-related differences in the presentation and course of Cushing's disease. J Clin Endocrinol Metab. 2003;88(4):1554–8.
   PubMedGoogle Scholar
• Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep. 2005;57(1):23–34.
   PubMedGoogle Scholar
• Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S, et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 2011;13(2):170–82.
   PubMedGoogle Scholar
• Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117(3): 399–412.
   PubMedGoogle Scholar
• Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 2007;6(5): 376–85.
   PubMedGoogle Scholar
• Hu Z, Wang H, Lee IH, Du J, Mitch WE. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest. 2009;119(10):3059–69.
   PubMedGoogle Scholar
• Kuo T, Lew MJ, Mayba O, Harris CA, Speed TP, Wang JC. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc Natl Acad Sci U S A. 2012;109(28):11160–5.
   PubMedGoogle Scholar
• Ragnarsson O, Burt MG, Ho KK, Johannsson G. Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy. Eur J Endocrinol. 2013;168(2):243–51.
   PubMedGoogle Scholar
• Wang W, Wang Z, Faith MS, Kotler D, Shih R, Heymsfield SB. Regional skeletal muscle measurement: evaluation of new dual-energy X-ray absorptiometry model. J Appl Physiol (1985). 1999;87(3):1163–71.
   PubMedGoogle Scholar
• Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care. 2005;8(3):311–7.
   PubMedGoogle Scholar
• Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3(3):181–90.
   PubMedGoogle Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.
   PubMedGoogle Scholar
• Strandberg S, Wretling ML, Wredmark T, Shalabi A. Reliability of computed tomography measurements in assessment of thigh muscle cross-sectional area and attenuation. BMC Med Imaging. 2010;10:18.
   PubMedGoogle Scholar
• Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R. A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord. 1994;18(4):219–34.
   PubMedGoogle Scholar
• Maden-Wilkinson TM, McPhee JS, Rittweger J, Jones DA, Degens H. Thigh muscle volume in relation to age, sex and femur volume. Age (Dordr). 2014;36(1):383–93.
   PubMedGoogle Scholar
• Mattsson S, Thomas BJ. Development of methods for body composition studies. Phys Med Biol. 2006;51(13):R203–28.
   Google Scholar
• Yamada Y, Ikenaga M, Takeda N, Morimura K, Miyoshi N, Kiyonaga A, et al.; Nakagawa Study. Estimation of thigh muscle cross-sectional area by single- and multifrequency segmental bioelectrical impedance analysis in the elderly. J Appl Physiol (1985). 2014;116(2):176–82.
   PubMedGoogle Scholar
• Ogawa M, Yasuda T, Abe T. Component characteristics of thigh muscle volume in young and older healthy men. Clin Physiol Funct Imaging. 2012;32(2):89–93.
   PubMedGoogle Scholar
• di Prampero PE, Narici MV. Muscles in microgravity: from fibres to human motion. J Biomech. 2003;36(3):403–12.
   PubMedGoogle Scholar
• Kramer HR, Fontaine KR, Bathon JM, Giles JT. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 2012;64(8):2438–50.
   PubMedGoogle Scholar